Therapy News and Research

RSS

Study shows pro-inflammatory cytokine TNF-α can speed recovery in mouse with pulmonary fibrosis

Inflammation has long been considered an integral part of the biological process that leads to deadly scarring in idiopathic pulmonary fibrosis. New research at National Jewish Health, however, suggests that a little inflammation may also be crucial to the healing and repair processes in the lungs.

26 Apr 2014

Engineering breakthrough allows cancer researchers to create living tumors

Drexel's Wei Sun, PhD, Albert Soffa chair professor in the College of Engineering, has devised a method for 3D printing tumors that could soon be taking cancer research out of the petri dish.

26 Apr 2014

UCSF researchers discover natural way to avoid urinary incontinence

An ancient form of meditation and exercise could help women who suffer from urinary incontinence, according to a new study from UC San Francisco.

26 Apr 2014

Longer looks: Terri Schiavo case; stem cell tourism in China; fall protection for the elderly

Increasingly, Big Pharma is betting on new blockbuster cancer drugs that cost billions to develop and can be sold for thousands of dollars a dose. In 2010, each of the top 10 cancer drugs topped more than $1 billion in sales, according to Campbell Alliance, a health-care consulting firm. A decade earlier, only two of them did.

25 Apr 2014

Researchers develop gene therapy reversing memory loss in mice with early-stage Alzheimer's

Alzheimer's disease is the first cause of dementia and affects some 400,000 people in Spain alone. However, no effective cure has yet been found. One of the reasons for this is the lack of knowledge on the cellular mechanisms which cause alterations in nerve transmissions and the loss of memory in the initial stages of the disease.

25 Apr 2014

Variant of cell surface protein may help develop drugs for gastric cancer

A team of scientists led by a researcher from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore has identified the cancer specific stem cell which causes gastric cancer. This discovery opens up the possibility of developing new drugs for the treatment of this disease and other types of cancers.

25 Apr 2014

Amedisys to pay $150 million to settle Medicare fraud case

Amedisys Inc., one of the nation's largest home health providers, will pay $150 million to settle claims that it exaggerated Medicare billings and had improper financial relations with referring physicians, the Department of Justice revealed. Meanwhile McClatchy is reporting that, based on an analysis of Medicare's list of banned providers, Miami is at the top for Medicare fraud.

25 Apr 2014

TB Alliance advances first-ever TB drug regimen to global Phase 3 clinical trial

Based on positive results from earlier clinical studies, TB Alliance is advancing the first-ever drug regimen designed to treat both drug-sensitive and some forms of multi-drug resistant tuberculosis (TB) to a global Phase 3 clinical trial.

25 Apr 2014

Cook Medical launches Stemulate Pooled Human Platelet Lysate cell culture media supplement

Cook Medical will introduce its Stemulate Pooled Human Platelet Lysate cell culture media supplement at the 2014 International Society for Cellular Therapy meeting, April 23-26.

From COOK MEDICAL INC. 25 Apr 2014

Targeting B cells may help reduce disease activity for people with multiple sclerosis

A new study suggests that targeting B cells, which are a type of white blood cell in the immune system, may be associated with reduced disease activity for people with multiple sclerosis (MS).

25 Apr 2014

Georgia State researcher receives grant to develop novel therapeutics against RSV infection

Dr. Richard Plemper, a professor in the new Institute for Biomedical Sciences at Georgia State University, has received a five-year, $2.83 million federal grant to develop novel therapeutics against Respiratory Syncytial Virus (RSV) infection.

25 Apr 2014

Measuring tumors' oxygen levels could help doctors make decisions about treatments

Unlike healthy cells, cancer cells thrive when deprived of oxygen. Tumors in low-oxygen environments tend to be more resistant to therapy and spread more aggressively to other parts of the body.

25 Apr 2014

Study offers evidence supporting use of autologous stem cell-based treatment for stroke

People who have had a stroke, often suffer motor deficits with little potential to restore neurological function.

25 Apr 2014

ASTRO’s guideline details use of adjuvant radiation therapy in treatment of endometrial cancer

The American Society for Radiation Oncology (ASTRO) has issued a new guideline, "The Role of Postoperative Radiation Therapy for Endometrial Cancer: An ASTRO Evidence-Based Guideline," that details the use of adjuvant radiation therapy in the treatment of endometrial cancer.

25 Apr 2014

Researcher finds relationship between motor skill deficiencies and severity of autism

An Oregon State University researcher has found a relationship between motor skill deficiencies and the severity of the symptoms of autism spectrum disorder in very young children.

25 Apr 2014

First Edition: April 24, 2014

Today's headlines include a number of reports about how the health law is playing in midterm election campaigns.

25 Apr 2014

Zenalux, RPCI collaborate to enhance Zenascope system to detect oral cancers at an early stage

Zenalux Biomedical, Inc., a leader in biophotonic diagnostics, is working with Roswell Park Cancer Institute to further enhance its flagship Zenascope™ product by adding a high-resolution camera to the system.

25 Apr 2014

Biogen Idec's revenue increases 51% to $2.1 billion in first quarter 2014

Biogen Idec Inc. today reported first quarter 2014 results, including revenue of $2.1 billion, a 51% increase compared to the first quarter of 2013.

23 Apr 2014

Nearly 179 million cases of acute diarrhea occur each year in the U.S.

In the United States, approximately 179 million cases of acute diarrhea occur each year, and most of those cases are entirely preventable, a researcher from The University of Texas Health Science Center at Houston concluded in a New England Journal of Medicine review article.

23 Apr 2014

Captisol-enabled Melphalan meets primary end points in phase 2 pivotal trial

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced that its pivotal trial of Captisol-enabled (propylene glycol-free) Melphalan met its primary end points.

23 Apr 2014

Therapy News and Research

Study shows pro-inflammatory cytokine TNF-α can speed recovery in mouse with pulmonary fibrosis

Engineering breakthrough allows cancer researchers to create living tumors

UCSF researchers discover natural way to avoid urinary incontinence

Longer looks: Terri Schiavo case; stem cell tourism in China; fall protection for the elderly

Researchers develop gene therapy reversing memory loss in mice with early-stage Alzheimer's

Variant of cell surface protein may help develop drugs for gastric cancer

Amedisys to pay $150 million to settle Medicare fraud case

TB Alliance advances first-ever TB drug regimen to global Phase 3 clinical trial

Cook Medical launches Stemulate Pooled Human Platelet Lysate cell culture media supplement

Targeting B cells may help reduce disease activity for people with multiple sclerosis

Georgia State researcher receives grant to develop novel therapeutics against RSV infection

Measuring tumors' oxygen levels could help doctors make decisions about treatments

Study offers evidence supporting use of autologous stem cell-based treatment for stroke

ASTRO’s guideline details use of adjuvant radiation therapy in treatment of endometrial cancer

Researcher finds relationship between motor skill deficiencies and severity of autism

First Edition: April 24, 2014

Zenalux, RPCI collaborate to enhance Zenascope system to detect oral cancers at an early stage

Biogen Idec's revenue increases 51% to $2.1 billion in first quarter 2014

Nearly 179 million cases of acute diarrhea occur each year in the U.S.

Captisol-enabled Melphalan meets primary end points in phase 2 pivotal trial

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News